Future Medicine Balance Sheet Health

Financial Health criteria checks 0/6

Insufficient data to determine the health of Future Medicine

Key information

n/a

Debt to equity ratio

n/a

Debt

Interest coverage ratio	n/a
Cash	n/a
Equity	n/a
Total liabilities	n/a
Total assets	n/a

Recent financial health updates

No updates

Recent updates

In this section we usually analyse Future Medicine's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. Future Medicine has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.

Financial Position Analysis

Short Term Liabilities: Insufficient data to determine if A341170's short term assets cover its short term liabilities.

Long Term Liabilities: Insufficient data to determine if A341170's short term assets cover its long term liabilities.

Debt to Equity History and Analysis

Debt Level: Insufficient data to calculate A341170's net debt to equity ratio to determine if it is satisfactory.

Reducing Debt: Insufficient data to determine if A341170's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: Insufficient data to determine if A341170's debt is well covered by operating cash flow.

Interest Coverage: Insufficient data to determine if A341170's interest payments on its debt are well covered by EBIT.

Balance Sheet

Discover healthy companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/20 20:06
End of Day Share Price	2024/12/20 00:00
Earnings	N/A
Annual Earnings	N/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Future Medicine Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution